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Abstract
Cellular senescence, a state of irreversible cell cycle arrest, is thought to help protect an organism from cancer, yet also
contributes to ageing. The changes which occur in senescence are controlled by networks of multiple signalling and
feedback pathways at the cellular level, and the interplay between these is difficult to predict and understand. To unravel
the intrinsic challenges of understanding such a highly networked system, we have taken a systems biology approach to
cellular senescence. We report a detailed analysis of senescence signalling via DNA damage, insulin-TOR, FoxO3a
transcription factors, oxidative stress response, mitochondrial regulation and mitophagy. We show in silico and in vitro that
inhibition of reactive oxygen species can prevent loss of mitochondrial membrane potential, whilst inhibition of mTOR
shows a partial rescue of mitochondrial mass changes during establishment of senescence. Dual inhibition of ROS and
mTOR in vitro confirmed computational model predictions that it was possible to further reduce senescence-induced
mitochondrial dysfunction and DNA double-strand breaks. However, these interventions were unable to abrogate the
senescence-induced mitochondrial dysfunction completely, and we identified decreased mitochondrial fission as the
potential driving force for increased mitochondrial mass via prevention of mitophagy. Dynamic sensitivity analysis of the
model showed the network stabilised at a new late state of cellular senescence. This was characterised by poor network
sensitivity, high signalling noise, low cellular energy, high inflammation and permanent cell cycle arrest suggesting an
unsatisfactory outcome for treatments aiming to delay or reverse cellular senescence at late time points. Combinatorial
targeted interventions are therefore possible for intervening in the cellular pathway to senescence, but in the cases
identified here, are only capable of delaying senescence onset.
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Introduction
Cellular senescence, characterised by permanent cell cycle
arrest, plays an important but complex role both in ageing and
cancer. Like apoptosis, cell senescence is a cell-autonomous
tumour protection mechanism [1,2]. Senescent cells can persist
in tissues for long periods of time and at relatively high frequencies
[3–5]. They secrete bioactive peptides [6,7], generate and release
reactive oxygen species (ROS) [8,9], which can promote
tumourigenicity and metastasis in adjacent cells with disabled cell
cycle checkpoints [10,11]. The same mechanisms generate DNA
damage, enhanced ROS production and senescence in somatic
bystander cells [12,13]. Thus, senescent cells may contribute to
loss of tissue homeostasis with ageing. It has been shown that
targeted ablation of senescent cells significantly delayed age-
associated loss of function in multiple tissues in a progeria mouse
model [14]. Furthermore, suppression of pro-inflammatory and
pro-oxidant signals emanating from senescent cells while
maintaining cell cycle arrest (i.e. the cell-autonomous tumour
suppressor function of senescence) shows promise as a future anti-
ageing intervention in humans [15]. To deliver on this promise, an
improved understanding of the complex interactions between the
multiple dysfunctional cellular processes that govern senescence is
needed.
The most central of these processes involves accumulation of
DNA damage and increased levels of ROS [8]. ROS arise mainly
from mitochondrial activity, being generated as a by-product of
energy production [16], and ROS-induced damage affects
multiple cellular constituents and functions. Importantly, ROS
damage mitochondrial DNA (mtDNA) and so impair mitochon-
drial function [17,18]. In response to damage, numerous signalling
pathways are activated and these are often reinforced through
feedback loops [6,9,19]. Oxidative stress activates c-Jun N-
terminal kinase (JNK) [20], which is responsible for FoxO3a
translocation to the nucleus via phosphorylation [21,22]. This then
promotes transcription of the genes CDKN1A and CDKN1B,
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which control cell cycle arrest [21,23]. Nuclear FoxO3a also
expresses the genes LC3, Gabarapl1 and Atg12 [24,25] inducing
autophagy, a cellular recycling process which is negatively
controlled by the insulin/TOR signalling pathway [26]. Inhibition
of insulin signalling, particularly Akt activity, promotes transcrip-
tion of FoxO3a genes (Daf-16 in C. elegans) and extends lifespan
in worms [27,28]. Inhibition of TOR (by caloric restriction or
pharmacological intervention) and activation of AMPK (by
resveratrol or metformin treatment) increase autophagy by
regulating ULK1 [29–31]. AMPK, in cooperation with SIRT1,
increases transcription and modulation of FoxO3a and PGC-1a
[32–34], while PGC-1a was also found, in addition to the effects of
AMPK activation [35], to be controlled via mTORC1 [36,37].
Once activated, PGC-1a promotes mitochondrial biogenesis,
increasing total mitochondrial mass and mitochondrial membrane
potential (ym) [38]. This leads to an increase in cellular energy
production (as ATP), and possibly also to increased ROS
generation.
As may be seen from this brief summary of the interconnected
pathways associated with cellular senescence, there is a need not
only to draw together the various elements into an integrated
framework, but also to do so in a way that allows the quantitative
dynamics to be examined and eventually understood. This is a
challenge that necessitates a systems-biology approach. Although
individual actions and reactions within the network have been
established by targeted experiments, the dynamic properties of the
system as a whole are more complicated than can properly be
understood without the aid of mathematical modelling. In
particular, modelling is likely to prove essential for identifying
the consequences of more complex interventions than alterations
to single elements, and thus for exposing possible paths for novel
therapies against the many age-related conditions to which cellular
senescence contributes.
We describe here the development of a comprehensive
dynamical model of irradiation-induced cellular senescence. Using
this model, we studied ROS-mTOR-dependent mechanisms of
restoring mitochondrial phenotype and function. We first predict-
ed in silico and then verified in vitro that it is possible to improve
the functional health of mitochondria either by scavenging ROS
or inhibiting mTOR, as single interventions. The model next
enabled investigation in silico of multiple, simultaneous parameter
perturbations, making it possible to probe in detail the ‘state space’
of the senescent phenotype. From this we identified two possible
interventions which should improve the cellular state. The first was
the use of combined inhibition of ROS and mTOR. We tested this
in vitro and confirmed that the dual inhibition resulted in
improved mitochondrial status and reduced DNA damage. The
second was the use of combined activation of AMPK and
mitophagy. Again, this improved cellular function and identified
the cellular control of energy status and turnover as being integral
to controlling the induction (or avoidance) of senescence. Whilst
combined interventions improved mitochondrial function, none
were able to restore it to a pre-senescent state. Using sensitivity
analysis, we identified that mitochondrial autophagy (mitophagy)
affected new mitochondria but not old mitochondria, suggesting a
decrease in mitochondrial fission over time. The impairment in
mitochondrial turnover in combination with increased mTORC1-
dependent mitochondrial biogenesis provides a theoretical expla-
nation for the global mitochondrial mass increase in senescence.
Measures of mitochondrial fusion and fission validated this finding
in senescent cells. Interestingly, in all interventions, we also
detected a gradual loss in treatment effectiveness at late time
points: after 18 days post-senescence induction, all interventions
became largely ineffective. We explored this finding using dynamic
sensitivity analysis, and obtained novel evidence for the existence
of a stable late-senescence state, characterised by poor sensitivity
and high variability across the network. This points to cellular
senescence being a locked, dysfunctional state which presumably
exists to protect the organism against the risk that might otherwise
be posed by continued proliferation of a badly damaged cell.
Results
Development of a dynamic model for cellular senescence
The model presented in Figure 1A integrated five key regulators
of cellular ageing: insulin-TOR, FoxO3a, DNA damage response
(DDR), ROS, and mitochondrial function. The insulin and
insulin-like growth factor 1 (IIS)-TOR network was abstracted
[from 39,40] in order to represent as simply as possible (consistent
with capturing the functional essence) the dynamics of Akt,
mammalian TOR Complex I (mTORC1) and the mTORC1-
p70-S6K-induced negative feedback loop. The mammalian TOR
Complex II (mTORC2) was not included explicitly but is
represented in its contribution to Akt-pS473, which is a readout
for both the mTORC1-p70-S6K-negative feedback and insulin-
mTORC2 activity, independent of the negative feedback loop
[39]. For FoxO3a, we modelled the main processes of synthesis
governed by an activated DNA damage response (via ATM
interactions), translocation from the nucleus to the cytoplasm,
subsequent ubiquitination as regulated by Akt, and an opposing
translocation regulated by JNK activity [21,22]. The dynamics of
Akt-pT308 and Akt-pS473 overlap, and by selecting Akt-pS473
we could model both the Akt-pS473-dependent regulation of
FoxO3a and the Akt-pT308-dependent activation of mTORC1 in
one step. Cell cycle arrest was followed in the model via the cell
division kinase inhibitors 1A (CDKN1A, also known as p21) and
1B (CDKN1B, also known as p27), whose levels were regulated
negatively via Akt [41] and positively via the transcriptional
activity of FoxO3A and DNA damage/p53. The nutrient (amino
acid)–dependent regulation of mTORC1 was also included along
Author Summary
Ageing is characterised by a gradual loss of homeostasis
within organs, which is known to be driven by the
accumulation of senescent cells. Cellular senescence helps
prevent cells from becoming cancerous, but their detri-
mental effect on organ function becomes debilitating
once they accumulate. These cells are particularly difficult
for the body to remove, and therefore understanding what
controls their survival and interactions within the organ is
important to combat age-related disease. We present a
mathematical model for cellular senescence. This model is
used for predicting drug interventions for restoring
function in cellular senescence. Whilst these interventions
were predicted and tested in vitro, showing improved
function and phenotype, none was able to restore cells to
a pre-senescent state. Our model includes mitochondria,
the power-plants of the cell, and we identify impairment of
their turnover coupled with increased mitochondrial
biogenesis as a mechanism which explained the long-
term failure in drug intervention. Finally, we predict that
the system dynamics stabilise in a new late-senescence
state, characterised by limited network response to
treatment and increased system vulnerability. This study
shows formally for the first time the dynamics of cellular
senescence as a system network and proves the require-
ment of early intervention in order to delay cellular
senescence.
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with the energy-dependent regulation of AMPK via mitochondrial
function. mTORC1 was inhibited by AMPK indirectly via TSC2
phosphorylation [42] and directly via Raptor phosphorylation
[43]. mTORC1 and AMPK independently triggered mitochon-
drial biogenesis via PGC-1a [35,36]. In conjunction with FoxO3a
activation, AMPK was implemented to induce mitophagy [25].
Mitochondrial mass and function play important roles in cell
senescence: driven by signalling downstream of CDKN1A [9,17]
and mTOR [44], mitochondrial mass per cell increases in
senescence. This is associated with decreased mitochondrial
membrane potential, ym, and increased production of ROS,
together indicating mitochondrial dysfunction in senescence [17].
Increased ROS generate more DNA damage, driving a positive
feedback loop by maintaining activation of CDKN1A [9]. To
quantitatively model this, we added a mitochondrial module which
describes the mitochondrial population in a cell as two subpop-
ulations, ‘new’ and ‘old’. Biogenesis only generates ‘new’
mitochondria, which then develop (or degenerate) to ‘old’
mitochondria with the rate of conversion dependent on
CDKN1A. ‘New’ mitochondria are different from ‘old’ in terms
of amounts in the cell, membrane potential (and thus propensity
for ATP generation), ROS production and probability for
mitophagy. Under basal conditions, there are essentially only
new mitochondria in a cell. Total mitomass and membrane
potential are the sum of both subpopulations.
Finally, ROS were represented as inducing DNA damage and
activating JNK and mTORC1 (via ATM to TSC2 and/or IKK-b
to TSC1). In conjunction with mitophagy, ROS drove accumu-
lation of lipofuscin [45] and therefore an increase in senescence-
associated b-galactosidase (SA-b-gal).
Time-course analysis upon irradiation-induced
senescence
In vitro data collection. To calibrate the model, MRC5
fibroblasts were treated with X-ray irradiation (20 Gy), which
results in an irreversible cell cycle arrest and eventual acquisition
of a senescence phenotype [46]. In vitro experimental time course
data were collected up to 21 days after X-ray irradiation and
analysed by western blot for protein levels and phosphorylation
(Figure 1B). Immunofluorescence co-localisation of LC3 and
CoxIV were used to determine a time course for mitochondrial
degradation via mitophagy (representative images in Figure 1C).
Pink1 western blotting (Figure 1D), plus controls treated with
Bafilomycin A followed by live cell microscopy measuring
colocalization of mitochondrially targeted RFP with lysosomal
GFP (Figure S1) were used to further validate quantified data on
LC3-CoxIV co-localisation (Figure 1E). We also detected PGC-1a
(Figure 1D), which reported a consistent correlation with mTOR-
pS2448, in agreement with previously published data showing
mTORC1-dependent PGC-1a activation [36,37]. Therefore, we
condensed PGC-1a-dependent mitochondrial biogenesis regula-
tion into mTOR-pS2448-dependent signalling to reduce the
model complexity. DNA damage levels were determined by
cH2A.X immunofluorescence (Figure 1E). Live cell microscopy
was used for detecting mitochondrial mass and ym, and flow
cytometry for ROS levels. As an additional control, mitochondrial
mass was also detected and confirmed using flow cytometry
(Figure S2). Data for SA-b-gal were taken from previously
published data [9]. Finally, since our cell viability data were
constant along the time course (Figure S3), we decided to omit an
apoptosis module in the model. A table containing the complete
quantitative data set used to estimate the model parameters is
provided in Table S1.
In vitro and in silico time-course analysis. These 14
readouts were used to estimate and identify the parameters of the
model introduced in Figure 1A (see Materials and Methods,
Tables S2, S3, S4 and Figures S4, S5, S6, S7, S8, S9, S10, S11,
S12, S13, S14, S15, S16, S17, S18). The model simulation versus
in vitro quantification data upon X-ray irradiation is shown in
Figure 1E. Following irradiation, in vitro and in silico data showed
a dramatic increase in DNA damage foci followed by persistent
oxidative stress and inflammatory responses (ROS, JNK-pT183
and SA-b-gal) and consolidated cell cycle arrest as shown by
increased CDKN1A and CDKN1B levels as well as reduced Akt-
pS473 phosphorylation. Interestingly, mTOR-pS2448 levels
increased upon irradiation until days 7–10 and decreased
thereafter. Consistent with mTOR-pS2448 activation, new
mitochondria were created by mitochondrial biogenesis (mito-
chondrial mass). The mitochondrial ym showed a gradual
decrease from day 5, indicating that the mitochondrial mass from
day 7 until 21 represented mitochondrial networks of low ym.
This decrease in mitochondrial ym was responsible for the
decrease in energy levels (increase in AMP/ATP ratio level) as
shown by AMPK-pT172 activation. Mitophagy levels also
remained low in the first 10 days and then increased, consistent
with AMPK-pT172 levels and inversely with mTOR-pS2448
activity. FoxO3a-pS253 and total FoxO3a levels remained
generally stable along the time course, highlighting that
CDKN1A/B and mitophagy responses were governed more by
DNA damage and AMPK, respectively, than by FoxO3a.
Model prediction. The distinction of the internal mitochon-
drial states, new and old, allowed us to predict three essential
features for the two sub-populations of mitochondria: mass, ym
and turnover (Figure 1F). The population of new functional
mitochondria was characterised by a reduced mass and a high
ym. In contrast, the population of old dysfunctional mitochondria
showed an elevated mass and a low ym. The total mitochondrial
mass, associated to the in vitro observed mitochondrial
mass (Figure 1E), was determined predominantly by the old
Figure 1. A dynamic model for cellular senescence. (A) Graphical model integrating the insulin-TOR (IIS-TOR) signalling pathway (left), the DDR-
oxidative stress responses (top-right) and mitochondria (centre). The insulin-TOR signalling pathway regulated the anabolic process of mitochondrial
biogenesis, FoxO3a translocation to the cytoplasm followed by ubiquitination, and inhibition of cell cycle arrest (black reactions). AMPK signalling
promoted the catabolic pathway of mitophagy, but was also modelled to promote mitochondrial biogenesis (magenta reactions). Mitochondrial
membrane potential (ym) increased cellular energy levels (red reactions) deregulating AMPK, and enhanced intracellular ROS (blue reactions). DNA
damage and ROS triggered a stress response and consolidated cell cycle arrest. (B) Representative western blot data used for calibrating the model.
(C) Representative imaging data used for measuring co-localisation between mitochondria (COXIV) and lysosomes (LC3) at day 0 and 12. These data
were used for creating a time course for mitophagy activation as indicated in panel E.(D) Additional controls for mitophagy data using Pink 1 and
mitochondrial biogenesis using PGC-1a indicating correlation between mTOR-pS2448 and PGC-1a. (E) In silico versus in vitro time courses. The model
(red lines) was calibrated over experimental time course data (blue points) collected for 14 readouts in the network up to 21 days. The inputs are
amino acids/insulin (constant inputs) and irradiation (pulse input of 5 min which simulates 20 Gy X ray irradiation over 5 min). Experimental time
points (blue points) are mean +/21 standard deviation collected from 5 independent repetitions. N= number of data points used for fitting each
readout time course. The goodness-of-fit statistical measures x2 [61] and AIC [68] for this model are 70.4278 and 381.838, respectively. (F) Simulated
time-courses of the internal states for mitochondrial mass, ym and turnover.
doi:10.1371/journal.pcbi.1003728.g001
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sub-population (Figure 1F), whereas the total mitochondrial ym
(Figure 1E), was largely due to the new sub-population (Fig-
ure 1F). Throughout the time course, the model predicted a
gradual decrease in mitochondrial turnover, indicating an inability
to correctly eliminate old dysfunctional mitochondria over time.
The next step was to use our dynamic mTOR-mitochondria-ROS
model to predict in silico, and then test in vitro, modalities for
restoring mitochondrial function in cellular senescence.
ROS inhibition enhanced mitochondrial membrane
potential
Background. As ROS is a central driver for mitochondria
dysfunction we gradually inhibited the variable ROS in the model
and analysed the effects on mitochondrial ym along the time
course. As the model species associated to ROS is produced and
destroyed dynamically, we inhibited the ROS species continuous-
ly. To achieve this, we created a simulated ROS inhibitor able to
reduce ROS levels by up to 90% of the control level along the time
course (Figure S19A). Gradual levels of inhibition from 0%
(control) to 90% were also simulated.
Model prediction. Upon ROS inhibition the model predict-
ed an increase in the total mitochondrial ym after three days post-
irradiation. Interestingly, this increase was explained by the model
as being dependent on the new mitochondria population
(Figure 2A). Despite the ym increase, the model also predicted
that only high levels of ROS inhibition (.70%) were able to
maintain high levels of mitochondrial ym at later time points (.9
days). In contrast, milder levels of inhibition gradually lost their
effectiveness over time. This suggested that ROS inhibition (Figure
S19) could increase the mitochondrial ym but was not sufficient to
restore mitochondrial function, which was gradually overwhelmed
with time.
In vitro testing. These predictions were experimentally
tested in vitro by treating cells with exogenous ROS-scavenging
enzymes superoxide dismutase and catalase (SOD and CAT)
throughout the time course. This treatment had the effect of
decreasing cellular superoxide production throughout the time-
course (Figure S20A). By measuring ym (via TMRM/MTG ratio)
at days 15, 18 and 21 post-irradiation we observed a significant
increase in treated cells (Figure 2B and 2C). By matching in silico
to in vitro data, an increase in the TMRM/MTG ratio of 25–40%
was found to correspond to ROS-inhibition of 15–30% in the
model, confirming the model prediction that ROS levels impinge
upon mitochondrial membrane potential. Furthermore, as pre-
dicted by the model, differences in ym between SOD/CAT-
treated and control cells became smaller with time (Figure 2B)
despite non-diminishing efficiency of the treatment (Figure S20).
mTOR inhibition reduced mitochondrial mass
Background. TOR plays a crucial role in the regulation of
autophagy [30,31], mitochondrial biogenesis [36] and Akt
feedback [47,48]. Hence, we studied the consequences of TOR
inhibition on mitochondrial mass over the time course. Perturba-
tion of mTORC1 alone produces undesired effects in the insulin/
TOR signalling pathway: it reduces mTORC1-p70-S6K-depen-
dent negative feedback to the insulin receptor substrate (IRS) and
therefore hyperactivates Akt [49,50]. A cleaner approach was to
perturb both mTOR complexes simultaneously by intervening
with TOR kinase directly. Although mTORC2 was not included
in the model, we could still approximate inhibition of TOR kinase
by reducing the protein levels for both mTORC1 and Akt at the
same time. Since no turnover was included for the species
mTORC1 and Akt, it was sufficient to decrease their initial
protein levels to model their inhibition. Using this approach, we
simulated a TOR-specific inhibition, similar to Torin1 treatment
[51].
Model prediction. Upon mTOR inhibition the model
predicted a decrease in total mitochondrial mass to be already
detectable after three days post-irradiation, due primarily to a
decrease in mass not only of the old mitochondrial population, but
also of the new population (Figure 3A). The model also predicted
that an inhibition of mTOR by more than 20% would be sufficient
to maintain low mitochondrial mass levels along the time course.
Since mitochondrial biogenesis affects the population of new
mitochondria, inhibition of mTOR by more than 40% was
predicted to be detrimental for this group, compromising healthy
cellular function. A safe margin of intervention was predicted to be
between 10–20% inhibition, which maintained a moderate and
stable population of new mitochondria, and limited the old
dysfunctional population.
In vitro testing. These predictions were tested experimen-
tally and confirmed in vitro by treating cells with Torin1 (Figure
S20B) and measuring mitochondrial mass (using mitotracker
green) at 15, 18 and 21 days post-irradiation (Figure 3B and 3C).
Although the reduction in total mitochondrial mass matched the
prediction until day 18, the later time point showed high variation
and no decrease of mitochondrial mass within the Torin1 treated
cells. Similar to the ROS scavenging intervention, the earliest time
points were most effective, displaying a gradual loss of treatment
efficacy. These data suggest that until days 15–18 the cellular state
change from normal to senescence remained partially transient
and additional cellular dysfunction was occurring at late time
points.
Combined ROS-mTOR inhibition synergistically increased
mitochondrial membrane potential
Background. In the previous sections, the effects of ROS or
mTOR inhibition were predicted and tested, showing that the
former increased mitochondrial ym whereas the latter decreased
mitochondrial mass. At this stage, we wished to investigate the
outcome of a combined ROS-mTOR treatment. The aim was to
detect possible non-linear synergistic effects which could further
increase mitochondrial ym and maintain a reduced population of
mitochondria at later time points.
Model prediction. In exploring the perturbation space, the
model confirmed ROS inhibition as an effective treatment for
increasing mitochondrial ym, but also showed that mTOR
inhibition could play a role, particularly when combined with
ROS inhibition (Figure 4A, mitochondrial membrane potential).
The model indicated that this change in ym was largely due to the
population of new mitochondria, suggesting that these treatments
were ineffective in restoring functionality in the old population
(Figure S21). Interestingly, the synergy of a ROS-mTOR
combined treatment further increased mitochondrial ym as
compared to single interventions (Figure 4A). Despite this, the
model also predicted a shift of treatment effectiveness over time for
low levels of inhibition, which suggested that the treatment doses
should be increased in order to maintain a constant level of
mitochondrial ym.
The next step was the analysis of mitochondrial mass. The
model predicted a reduction in mitochondrial mass due predom-
inantly to mTOR inhibition, whereas ROS was not predicted to
be a major contributor (Figure 4A, mitochondrial mass). A weak
synergistic effect of ROS-mTOR combined intervention was
detected at day 21 although this did not show a significant
improvement when compared to a single mTOR inhibition.
Interestingly, at this time point the model predicted a clear
increase in mitochondrial mass upon ROS inhibition. In contrast
Cellular Signalling in Stress-Induced Senescence
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to the mitochondrial ym, the model predicted that these
treatments affected the mitochondrial mass for the populations
of both new and old mitochondria (Figure S21).
Mitochondrial dysfunction and ROS production are intercon-
nected with nuclear DNA damage in a positive feedback loop [9].
Therefore, we also predicted and tested the effect of a combined
treatment on the DNA damage response. The model showed a
decrease in DNA damage foci upon ROS, mTOR or combined
ROS-mTOR inhibition as compared to the control along the time
course (Figure 4A, DNA damage). Despite this, a combined ROS-
mTOR inhibition was not predicted to further reduce the number
of DNA damage foci as compared to the other treatments unless
higher doses were applied. Finally, it indicated that any treatment
gradually lost effectiveness over time, as shown by a gradual shift
towards the top-right corner of the plots.
In vitro testing. We experimentally tested these predictions
and detected a significant increase in ym following a combined
ROS-mTOR treatment as compared to the other treatments or
control at day 12 post-irradiation. Although a synergistic effect was
found at 12 days, synergism was lost at later time points and none
of the treatments rescued the decrease of ym with time completely
(Figure 4B), in agreement with the shift in treatment effectiveness
predicted by the model. The in vitro tests also confirmed a gradual
decrease in ym for all applied treatments. In particular, the
equivalence of all treatments at day 21 suggested a gradual loss in
treatment sensitivity, in agreement with the above hypothesis that
cellular pathways were still developing progressive dysfunction.
See upper panel in Figure 4C for representative images of ym for
control and dual perturbation of cells at day 21. We experimen-
tally tested the model predictions for the mitochondrial mass using
a combined SOD+Cat+Torin1 treatment (Figure 4B). In agree-
ment with the model, the in vitro data indicated mTOR as a main
contributor for mitochondrial mass. In contrast to the model
prediction, in vitro tests also showed a reduction in mitochondrial
mass upon ROS inhibition at 12, 15 and 18 days post-irradiation,
but, in agreement with the model, an increase in mitochondrial
mass at day 21. This partial discrepancy between in silico and in
vitro data, or within the in vitro time-course data, highlights the
Figure 2. ROS inhibition increased mitochondrial membrane potential. (A) Simulated time-courses for mitochondrial membrane potential
(ym). Gradual ROS inhibition from 0% (black, control) to 90% predicted an increase in mitochondrial ym due to perturbation of the new
mitochondrial population. (B) The model prediction was confirmed by measuring mitochondrial membrane potential by live cell imaging and
quantifying the fluorescence intensities (n = 3). Exogenous addition of SOD and catalase significantly increased the average ym (Mann-Whitney test, *
P,0.05) in vitro. In silico inhibition of ROS levels also partially reactivated mitochondrial ym in a dose dependent manner, with between 15 and 30%
levels giving equivalent restoration of ym to the in vitro data. In vitro mitochondrial ym was determined in MRC5 cells 15, 18 and 21 days post IR
using live cell imaging of cells loaded with the mitochondrial ym dependent dye TMRM and non-potential dependent mitotracker green. (C) Example
images of data used in (B) for control cells (upper panel) and cells treated with SOD and catalase (100 U each) in the medium (lower panel) for 15 days
post IR, stained with the mitochondrial ym dependent dye TMRM, the non-potential dependent dye mitotracker green, and the nuclear counterstain
Hoechst 33342. Scale bar is 10 mm.
doi:10.1371/journal.pcbi.1003728.g002
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complexity of ROS signalling. We also tested the model
predictions for the DNA damage by counting cH2A.X DNA
damage foci for each treatment combination at day 0 (control),
and at 18 and 21 days post-irradiation (Figure 4B). In vitro tests
showed a reduction in number of damage foci for each treatment
up until day 18. However, no clear improvement was detected by
a combined mTOR-ROS inhibition. At day 21 none of the
treatments reduced DNA damage foci frequencies, in agreement
with the previously advanced hypothesis of sensitivity loss at late
time points (see lower panel in Figure 4C for representative images
of DNA damage foci for control and dual perturbation at day 18).
Finally, we determined the downstream effect of inhibition on the
appearance of the senescence marker, SA-b-gal. We found that
there was a slight decrease in positive cells at early time points with
all interventions, and a significant decrease for combined ROS-
mTOR intervention at days 3 and 6, also with a notable decrease
in intensity of staining. However, by day 11 there was no
difference in positive cells between any of the treatments (Figure
S22).
Modelling predicts increased mitochondrial membrane
potential following AMPK, FoxO3a or mitophagy-
activating treatments
Background. Since the previous inhibitions negatively affect
anabolic processes, we decided to test the effects on the network of
single and double over-activation for protein species regulating
catabolic signalling pathways. AMPK, FoxO3a and mitophagy are
of particular interest in cellular senescence. Since no turnover was
included for the species AMPK, it was sufficient to increase its
initial protein level to achieve its over-activation. The species
FoxO3a and mitophagy were dynamically produced and de-
stroyed, so their over-activation was achieved by perturbation
throughout the time course. We created two simulated activators,
one for FoxO3a and one for mitophagy, aimed at increasing
FoxO3a or mitophagy levels by up to 150% of the control levels
along the time course (Figure S19B). Gradual levels of inhibition
from 0% (control) to 150% over-activation were also simulated.
Model prediction. The model predicted that AMPK over-
activation would reduce mitochondrial biogenesis, ym and induce
Figure 3. mTOR inhibition decreased mitochondrial mass. (A) Simulated time-courses for mitochondrial mass. Gradual mTOR specific
inhibition from 0% (black, control) to 90% predicted a decrease in mitochondrial mass due to the perturbation of the population of old mitochondria.
(B) The model prediction was confirmed by measuring mitochondrial mass using mitotracker green and quantifying the fluorescence intensities
(n = 3). Exogenous addition of 10 nM Torin1 significantly decreased the average mass (Mann-Whitney test, * P,0.05) in vitro. In silico inhibition of
mTOR levels also partially decreased mitochondrial mass in a dose dependent manner, with between 15 and 30% levels giving equivalent restoration
of ym to the in vitro data. (C) Example images of data used in (B) for control cells (upper panel) and cells treated with Torin in the medium (lower
panel) for 15 days post IR, stained with the mitochondrial ym dependent dye TMRM, the non-potential dependent dye mitotracker green, and the
nuclear counterstain Hoechst 33342. Scale bar is 10 mm.
doi:10.1371/journal.pcbi.1003728.g003
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mitophagy (Figure 5A, AMPK Activation). Interestingly, the
model also showed that all of the model components involved in
the DDR-oxidative stress response were gradually inhibited
(Figure 5 and Figure S23). Similar predictions were also found
by over-activating either FoxO3a or mitophagy in the network.
After analysing the effects of single perturbations, we simulated
mitochondrial mass or ym following a double over-activation of
FoxO3a-AMPK, or mitophagy-AMPK at day 15 after-irradiation
(Figure 5B). Interestingly, we found a synergistic protective effect
of dual intervention (as shown in dark red), with lower
mitochondrial mass (due to a decrease of old mitochondria) and
maintained ym. This was not obvious from the outcomes of the
single perturbations. This area was mostly dependent on AMPK
and, importantly, there was a rescue of ym in association with a
low mitochondrial mass. In conclusion, these results were
consistent with the single and double inhibitions of ROS and
mTOR, and therefore suggested that alternative therapeutic
interventions were also possible and potentially effective.
Figure 4. Combined mTOR-ROS inhibition increased mitochondrial membrane potential. (A) Model predictions were obtained by
plotting the intensity for each readout (membrane potential (ym), mitochondrial mass and DNA damage, respectively) with inhibition of mTOR (x
axis) and ROS (y axis). The control (no inhibition) is represented as the point (0, 0). Prediction data are shown at days 12, 15, 18 and 21 post-irradiation.
(B) In vitro ym, mitochondrial mass and DNA damage foci number upon inhibition of ROS, TOR or combined TOR-ROS at days 12, 15, 18 and 21, or 18
and 21 (for DNA damage foci). Cells were treated with 10 nM Torin1 (TOR inhibitor), or Torin1 with SOD and catalase (100 U each) (n = 3, ANOVA with
Dunn’s post-hoc test, * P,0.05 within time points). (C) Example images of data used in (B) for control cells (left panels) and cells treated with Torin1,
SOD and catalase in the medium (right panel) stained for ym and mitochondrial mass at day 21 (above panel) or for DNA damage foci at day 18
(lower panel).
doi:10.1371/journal.pcbi.1003728.g004
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Mitochondrial dysfunction is maintained by decreased
mitochondrial dynamics
Background. All interventions that we have tried within the
context of our model have been shown to alleviate some of the
symptoms of senescence, but none have been able to restore the
mitochondria in senescent cells to a pre-senescent state. Therefore
we performed a sensitivity analysis averaged over the time course
to identify the essential reactions that, according to the model,
determine mitochondrial parameters.
Model prediction. Using sensitivity analysis averaged over
the time course, we therefore investigated the role that each
mitochondrial-related kinetic rate constant played upon the
mitochondrial species within the model (Figure 6A). The two
most important reactions determining mitochondrial mass and
membrane potential were mTORC1-dependent mitochondrial
biogenesis and mitophagy of new mitochondria. AMPK-driven
biogenesis played a very minor role (kinetic rate constant k34). To
our surprise, the model predicted that variable mitophagy of old
mitochondria (rate constant k36) would essentially have no effect
on mass and membrane potential of either young or old
mitochondria. Finally, mitochondrial dysfunction (kinetic rate
constant k37), describing the rate of conversion of young into old
mitochondria driven by CDKN1A-p38-TGF-b signalling, only
affected the new mitochondria mass species, with concomitant
effects upon mitochondrial membrane potential (species618 and
621).
We next investigated the time courses of these species by
varying the above kinetic rate constants by factors ranging from
Figure 5. AMPK, FoxO3a, or Mitophagy simulated activations consistently improve mitochondrial function. (A) Model single
perturbation of AMPK, FoxO3a, or mitophagy from 0% (control, black) to 150% gradual over-activation. (B) Model double perturbations were
obtained by plotting the intensity for each readout (left, mitochondrial mass and on the right, membrane potential (ym)) with over-activation of
AMPK (x axis) and FoxO3a (y axis) (above), or AMPK (x axis) and mitophagy (y axis) (below). The control (no over-activation) is represented as the point
(0, 0). Prediction data are shown at 15 days post-irradiation.
doi:10.1371/journal.pcbi.1003728.g005
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f = 0.5 to f = 1.5. These results confirmed the sensitivity of new
mitochondrial mass upon mTORC1-dependent mitochondrial
biogenesis, mitophagy and (to a lesser degree) mitochondrial
dysfunction (Figure 6B, solid lines). Additionally, this analysis
showed that changes in these kinetic rate constants affected the
new mitochondria population only at the early time points (first
row, time,10 days), whereas changes in kinetic rate constants k33
(mTORC1 driven biogenesis) and k35 (mitophagy of new
mitochondria) affected the old mitochondrial population through-
out the time course. Interestingly, the kinetic analysis confirmed
that the increase in mass of old mitochondria was almost
exclusively driven by reactions (mTORC1 driven biogenesis and
mitophagy) acting only on the new mitochondria, but not by
mitophagy of old mitochondria themselves (Figure 6B).
We tested whether this surprising prediction could have been
precipitated by an artificial constraint in the model. In the original
model, mitophagy of old mitochondria was limited to be smaller
than that of new mitochondria to mimic the requirement for
mitochondrial fission (Table S2). However, the parameter
estimation without that constraint achieved the same result as
before (i.e. the value for mitophagy of old mitochondria remained
much smaller than that for new mitochondria). Hence, we left that
constraint in the model to minimise the computation time of the
parameter estimation.
In conclusion, sensitivity analysis predicted that the accumula-
tion of dysfunctional mitochondria in senescence would be caused
by the combination of an initial hyperactive mTORC1-dependent
mitochondrial biogenesis followed by impaired turnover of the
mitochondrial population. While more new mitochondria would
be generated, mitophagy of new mitochondria would be insuffi-
cient to degrade them before they degenerate into old mitochon-
dria, for which mitophagy would be even less efficient, resulting in
accumulation of old, dysfunctional mitochondria. Since mitophagy
was functional in our system throughout the time course
(Figures 1C, 1E, and S1), we were led to the hypothesis that the
turnover inefficiency for the old population was due to a decrease
in mitochondria fission events.
In vitro testing. Mitochondrial fission events are a pre-
requisite for mitophagy. The predicted insufficiency of mitophagy
might thus be related to low fission (and fusion) activity in
senescent cells. To test this hypothesis, we transduced young and
senescent MRC5 fibroblasts with a mitochondrially targeted
fluorescent protein and followed the mitochondrial network
movement over time. We detected a statistically significant
decrease in the number of both fusion and fission events in
senescent cells (Figure 6C and 6D) concomitant with decreased
mitochondrial movement (Movie S1). Therefore, decreased
mitochondrial dynamics may explain preferential targeting of
young mitochondria to mitophagy as well as increased mitochon-
drial mass in senescence, the latter by decreasing the available pool
of small mitochondria for mitophagy.
Complications in treating late senescence: a network-
wide perspective
Background. The previous sections indicated that therapeu-
tic treatments aiming to reduce ROS, mTOR or combined ROS-
mTOR levels could improve mitochondrial function and pheno-
type, although these treatments lost effectiveness at late time
points.
Model prediction. By splitting the total mitochondrial
population into new functional and old dysfunctional mitochon-
dria in the model, we predicted that the treatments mainly acted
on the former mitochondrial sub-population. This suggested that
the applied inhibitions could delay the senescence process but not
reverse it, as eventually the mitochondrial population became
dysfunctional. To investigate this hypothesis, we computed a
dynamical sensitivity analysis for the model, to study the dynamics
of the relationships between parameters in the whole model. To do
so, we computed the sensitivities of the model species upon
perturbing the model kinetic rate constant parameters at days 1,
10 and 20 post-irradiation (Figure 7). This aimed to identify which
of the species/modules within the network were still responsive at
later time points by investigating changes in sensitivity over time.
At day 1 post-irradiation (Figure 7, early senescence panel), the
IIS-TOR signalling pathway species, and in particular mitophagy,
showed effective sensitivity to both its internal kinetic rate
constants and mitochondrial dynamics. The DDR-ROS signalling
response was still low-moderate and the predominant signals
derived from mitochondria were still driven by the new
population. Mitochondrial species within the model were sensitive
to the IIS-TOR and mitochondrial kinetic rate constants.
Interestingly, the mitochondrial dynamics showed that mitochon-
drial biogenesis by mTORC1 (parameter k33) also promoted
mitochondrial dysfunction (species Mito-mass-old). Mitochondrial
kinetic rate constants affected ROS production and IIS-TOR-
AMPK pathways by affecting cellular energy levels (species
AMPK-pT172). Cell cycle arrest programs, shown by the species
CDKN1A and CDKN1B, were already started at day 1, being
mostly dependent on irradiation-induced DNA damage (param-
eter k19).
At day 10 post-irradiation (Figure 7, mid-senescence panel), the
DDR-ROS stress responses and mitochondrial dysfunction were
highly active. The DDR-ROS stress response species were affected
by almost all the model kinetic rate constants indicating that the
Figure 6. Mitochondrial dysfunction is driven by decreased mitochondrial dynamics. (A) Sensitivity analysis averaged along the time
course for the mitochondrial species in the model by varying the mitochondrial-related kinetic rate constant parameters. Mitochondrial biogenesis
was determined by mTORC1 signalling (k33) but not by AMPK (k34). Clearance of old mitochondria (k36) was not as effective as for new mitochondria
(k35). This reduced mitochondrial quality control for the old mitochondrial population implicated an increased and sustained global mitochondrial
dysfunction. Scale bar represents the normalised positive or negative sensitivity of each species to each rate constant. (B) In silico time courses over
21 days post-irradiation for the two states of mitochondrial mass (new and old) were computed by separately perturbing the previous kinetic rates by
different factors f (f = 1 is the control). These perturbations affected the new mitochondria only at early time points (,10 days), whereas the old
mitochondria were affected throughout the time course. Consistent with panel A, the perturbation of the parameters k34 and k36 (dotted lines) did
not alter the mitochondrial mass readouts and are therefore overlapped. (C) Representative live cell images of mitochondrial networks in young
(control) and senescent (sen) MRC5 fibroblasts. Mitochondrial networks were detected in deconvolved 3D confocal images using mitochondrially
targeted fluorescent protein. Individual parts of the cell mitochondrial population are identified using colour coding. Whole frame images are shown
in the upper panel, and the boxes highlight the areas (18.2 mm2) analysed for fusion and fission events over 30 minutes. Example images from these
areas over 140 s are shown below with the detected fusion and fission events highlighted with white and yellow arrows respectively. A timelapse
movie containing the full dataset from a control and senescent cell are available in Movie S1. (D) Quantification of observed fusion and fission events
in 18.2 mm2 areas from control and senescent cells. Events were recorded every 20 s over 30 minutes for each cell and expressed per minute and
relative to the mitochondrial mass in the area observed. Significant decreases were seen for both fusion and fission in senescent cells (Mann-Whitney,
p,0.001, n = 6 cells per sample with between 90–180 events recorded).
doi:10.1371/journal.pcbi.1003728.g006
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Figure 7. Dynamic sensitivity analysis. Sensitivity analysis at 1, 10 and 20 days post-irradiation indicated three states of cellular senescence: early,
middle and late senescence. Sensitivity analysis was computed for the model species (y axis) upon perturbation of the kinetic rate constant
parameters (x axis). The parameters k1–k11 are involved in the IIS-TOR signalling sub-network, whereas the groups of parameters k12–k32 and k33–
k41 regulate the DDR-ROS signalling response and mitochondrial dynamics, respectively. Model species sensitivities changed over time, highlighting
a dysfunction for mitophagy and mitochondria, and DDR-ROS stress-response at the later time points. These dysregulations consolidated over time
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overall network was sustaining a stress signalling response. In
particular, mitochondrial kinetics predominantly fed a stress
response by increasing ROS production and strengthening cell
cycle arrest, whose control was now driven by mitochondrial and
IIS-TOR signalling rather than by DDR-ROS rate constants. At
this stage, mitochondrial dysfunction (species Mito-mass-old) was
highly sensitive to the IIS-TOR signalling pathway dynamics,
positively by anabolic signals, such as Akt-mTORC1 (parameters
k1 and k7), and negatively by catabolic signals, such as AMPK-
FoxO3a (parameters k3 and k14) and mitophagy (parameter k9).
Interestingly, the overall sensitivity for the species mitophagy was
largely reduced, indicating a gradual loss in feedback response
from IIS-TOR and mitochondria. Conversely, mitophagy was
found to become increasingly regulated by DDR-ROS-dependent
kinetic rate constants. This gradual loss in sensitivity was also
found for the species representing the IIS-TOR signalling
pathway. These intermediate time-point results showed that the
network was highly dysregulated by severe mitochondrial
dysfunction, sustained DDR-ROS stress responses, and moderate
insensitivity of the IIS-TOR-mitophagy signalling pathway.
At day 20 post-irradiation (Figure 7, late senescence panel), the
network globally showed a decrease in sensitivity as compared to
the mid-senescence case. The species involved in the IIS-TOR
signalling pathway were only marginally affected by the overall
network dynamics, and in particular mitophagy was largely
insensitive. The DDR-ROS stress response and mitochondrial
dysfunction sensitivities were still sustained, although not as
markedly as before. Cell cycle arrest was preserved and
maintained by the kinetics of IIS-TOR, DDR-ROS and
mitochondria. In Figure 1E, both the in silico and in vitro time
courses suggested that the network was approaching stabilisation
after day 15. The sensitivity analysis described here validates this
observation of the stabilisation to a senescent phenotype. To
formally test the stability of this cellular senescence state, we
calculated the Lyapunov exponents of the model (which allowed us
to determine the network stability over time) and concluded that
the model was asymptotically Lyapunov stable, since the 19
computed Lyapunov exponents were all negative (Table 1). This
indicated that the variable levels eventually reach equilibrium.
Although this state of cellular senescence, that we term late
senescence, was dynamically stable, this did not mean that its
variance was low. In fact, the global decrease in sensitivity upon
kinetic rate constants indicated that the semantics of these model
parameters, e.g. promoter or inhibitor, became more uncertain.
As a consequence, this uncertainty increased system noise and
decreased network robustness, which, in the context of a cell,
translated into weak signalling regulations and therefore poor
intervention effectiveness. We tested this prediction by simulating
the model stochastically and observed an increase in variance
especially for the oxidative stress/DNA damage signalling and to a
lesser extent for the Mitophagy and mitochondrial mass species
(Figure S24). In agreement with these predictions, our experi-
mental data (Figures 1E, 2B, 3B and 4B) indicated an increase in
variance at late time points and a loss in intervention effectiveness
for ROS, mTOR or ROS-mTOR interventions at day 21. In
particular, we attributed this gradual loss in intervention
effectiveness to 1) gradual loss of mTOR-Akt sensitivity upon all
the kinetic rate constants in the network, and 2) persistent
dysfunction in mitophagy and mitochondria, ultimately largely
unaffected by ROS inhibition.
This network-wide exploration of the model dynamic sensitivity
explained why our interventions were only effective until late
senescence and then ultimately lost effectiveness. Hence, the
investigation of this cellular state of senescence showed intrinsic
difficulties in applying intervention to delay or reverse this state to
normal due to multiple severe dysfunctions within the network
concomitant with a global loss of network sensitivity.
Discussion
The medium to long term effect of stress-induced senescence
has previously been investigated with a focus on DNA damage-
activated p53 and cell cycle arrest [52], but not in any detail with
regard to other players implicated in cellular senescence. In this
work, we used a systems biology approach to build the first
detailed mathematical model to address cellular senescence. We
performed a temporal analysis of the changes that occur in stress
activated signalling, bioenergetic and cell cycle signalling, and
their effects upon one another over a three week time course of
irradiation-induced senescence. The data showed a complex
phenotype of changing behaviour over time for many parameters.
Of particular interest were the changes in mitochondrial mass,
activity and turnover, which directly affect energy production and
cause further stress and damage via ROS production. We
observed large changes in both mitochondrial mass and
membrane potential, neither of which were rescued by the modest
increase in mitophagy. Due to the complexity of these interacting
pathways, a model was designed to represent the dynamical
process of irradiation-induced cellular senescence. Although
inevitably somewhat abstracted, this model fitted our in vitro
data, suggesting that the network representation was a close
approximation to the biological system that we wanted to
investigate. Importantly, such a system enabled us to investigate
strategies of drug interventions that might reduce senescence
progression in the medium to long term. In silico predictions
indicated that mitochondrial ym and mass could be restored by
scavenging ROS or inhibiting mTOR. However, the model also
indicated loss of effectiveness of interventions at late time points. A
combination of the two treatments was shown to out-perform the
previous results, and to reduce DNA damage. In vitro tests
confirmed these predictions and also highlighted an increase in
variance at late time points. Finally, these simulated interventions
were further supported by predicting the network behaviour upon
over-activation of AMPK, FoxO3a or mitophagy, indicating the
central role of energy and turnover in inducing senescence.
Whilst the model does not specifically include fusion and fission,
the detailed modelling of the shift between freshly generated and
aged mitochondria allowed us to infer differences in fission rates in
senescence. Fusion and fission are tightly coupled, required for
mitophagy of mitochondria [53], essential for removal of damaged
mitochondria with reduced ym and may have deep evolutionary
origins connected with ageing [54]. Our measurements of fusion-
fission show a decrease in both processes in senescence, whilst
maintaining a tight coupling between them in terms of their
frequencies. Lower fission therefore explains the lack of mitophagy
increase, even though there is apparently a large increase in the
necessary proteins. A recent investigation into fusion and fission in
neurodegenerative disease models identified similar findings, with
reduced rates of fusion and fission [55]. In this study, the authors
also showed that mitochondrial motility was essential for fusion.
and ultimately attenuated the global sensitivity in the model. Scale bar represents the normalised positive or negative sensitivity of each species to
each rate constant.
doi:10.1371/journal.pcbi.1003728.g007
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Whilst not quantified, we observed a similar decrease in motility in
our senescence model, highlighting the overlap between neuronal
disease and cellular ageing. It is therefore possible that the
decreased fusion-fission in senescence is due to decreased
mitochondrial motility, a factor which is known to induce
mitochondrial diseases in some cases of familial Parkinson’s
disease [56]. Intracellular motility was not encapsulated in our
model, and therefore would be important to address in future
models investigating mitochondrial dysfunction.
Over the induced senescence time course, why were the
treatments effective only up until a late-senescence state? Which
were the signalling pathways involved in this dysfunction? What
was the nature of this cellular senescence late state? What was its
role? Could the dysregulation be reversed? To answer these
questions, we computed a dynamic sensitivity analysis and
detected a gradual loss in network sensitivity and, in particular,
a deficiency in the IIS-TOR signalling pathway and mitophagy
regulation at late time points. Although we proved the asymptotic
stability of this cellular senescence state, the overall poor sensitivity
in the network also predicted two negative consequences: the
detected loss in treatment efficacy and increase in network
variance. The former indicated that the further the system went
into late-senescence, the more combinatorial treatments were
required to alleviate the phenotype due to the multiple cellular
dysfunctions that were apparent at later time points. The latter
implied that the network was less capable of responding to
signalling programs due to high variance within the system. In this
prediction, a cell in the late-senescence state would not only be
intrinsically dysfunctional, but also more susceptible to external
insults, due to loss of effectiveness in the response mechanisms.
Aside from late senescence, the model also predicted the
mechanism underlying the transition from normal to early
senescence. Interestingly, it indicated that multiple factors, such
as DNA damage, increased ROS production and gradual
mitochondrial dysfunction, are all likely to be playing a role in
this transition. These players would mutually re-enforce their
activation in the signalling network. In the specific case of
irradiation-induced senescence, this synergistic transition
would start from DNA damage production and loss of
mitochondrial function. Subsequently, in early-mid senescence
the cellular decision appears to reach a crossroad, with
anabolic signalling driving further damage and catabolic
signalling tending to suppress it. All of these events lead
eventually to a persistent cell cycle arrest and an initial drive of
mTOR-dependent mitochondrial biogenesis and autophagy
[57] in order to replace damaged mitochondria and restore
cellular energy levels. This over-activation of mitochondria in
combination with increased cellular stress activation promotes
the formation of dysfunctional mitochondria, over-riding
mitochondrial turnover by mitophagy, and accumulating
cellular damage. Hence, although mTOR represents an
essential player in this reinforcement loop, our data suggest
that other drivers, such as DDR and ROS, are also required in
irradiation-induced senescence.
Despite its power, the current model misses some components
that are likely to be important. Most significant of these is the
complexity of the inflammatory system as controlled by NF-kB,
TNF-a and TGF-b signalling pathways. This inflammatory
response is heavily abstracted in this model by JNK through
ROS regulation. The full inflammatory system has important
positive-feedback loops that may develop independently and may
therefore be responsible for permanent activation of JNK, and
contribute to ROS signalling stabilisation (Jurk et al., Nature
Comm., in press). Control of pro-inflammatory cytokine produc-
tion and activation of other members of the senescence associated
secretory phenotype would obviously impinge upon the pathway
to cellular senescence [58–60]. If added to a future version of this
model, these would allow a detailed investigation of the
development of senescence within a multi-cellular environment
where paracrine signals are operative. Finally, the mitochondrial
dynamics of fusion and fission were also abstracted, due to the
difficulty of representing their regulation in the network. Their role
in mitochondrial homeostasis would warrant inclusion in future
work. Nevertheless, the abstraction applied in this study was
sufficient for the conclusions provided, and represents, we believe,
a worthwhile advance.
In conclusion, the nature of the biological pathways driving
cellular senescence presents a challenge to gaining a sufficient
understanding in order to identify novel targeted therapies against
the many age-related diseases. A considerable contribution in
representing this highly networked biological system and eliciting
its properties is offered by mathematical modelling.
Using an integrative systems-biology approach, we determined
that multiple interventions for limiting the progression of
senescence, and therefore the impact on age-related diseases, are
possible: these include down-regulation of ROS and mTOR. Due
to the increase in cellular dysfunction over time, these interven-
tions should be applied at early stages and possibly integrated with
other interventions aimed at regenerating mitochondria and
mitophagy, and reducing inflammation.
Table 1. Model Lyapunov exponents.
Lyapunov Exponents
l1 20.0136218
l2 20.0052144
l3 20.0748144
l4 20.0660512
l5 20.154906
l6 20.175105
l7 20.352563
l8 20.403684
l9 20.44979
l10 20.947157
l11 21.10172
l12 21.96465
l13 23.41447
l14 25.19749
l15 234.4987
l16 257.6887
l17 21094.69
l18 22694.43
l19 25721.87
Sum 29617.50
Avg divergence 29616.65
The Lyapunov exponents computed for this model were all negative, indicating
that the model was asymptotically Lyapunov stable and therefore the
trajectories eventually converged to an equilibrium.
doi:10.1371/journal.pcbi.1003728.t001
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Materials and Methods
Mathematical model
The Ordinary Differential Equation (ODE) mathematical
model consists of 23 variables and 41 mass action reactions
covering 5 cellular modules: DNA-damage, oxidative stress, FoxO,
IIS-mTOR and mitochondria. There are 3 inputs: insulin, amino
acids and irradiation. The first two inputs were set as constants,
whereas the irradiation input was an impulse at time 0 for 5 min,
consistent with the in vitro cell treatment. The cells were not
starved by insulin or amino acids pre-irradiation to avoid cell
death upon irradiation, and this was modelled by assuming an
equal protein amount fixed at the basal level for both the
phosphorylated and dephosphorylated states across the IIS-TOR
signalling pathway. In pre-irradiated cells, the stress response
induced by DNA-damage and ROS was low but still present and
all the variables directly involved in these signalling pathways
(DNA-damage, ROS, JNK, SA-b-gal, IKK-b) were set to reflect
this initial basal level. In the model, the mitochondrial population
was split into discrete groups: new and old. For the initial state,
amounts for the new group (Mitochondrial-Mass-new, Mitochon-
drial-Membrane-Potential-new) were set to basal levels, whereas
amounts for the old group (Mitochondrial-Mass-old, Mitochon-
drial-Membrane-Potential-old) were assumed negligible as in
healthy cells, dysfunctional mitochondria are usually removed by
mitophagy. The model was linked to the in vitro data by 14
observables covering the entire network. Where the observable
provided a composite measure of states, such as nuclear/
cytoplasmic FoxO3a or the sub-populations of mitochondria, the
respective observable was linked to the sum of these states. Hence,
the observable FoxO3a-total was associated to the sum of nuclear
and cytoplasmic FoxO3a species, the observable Mitochondrial-
Mass was associated to the sum of Mitochondrial-Mass-new and –
old and the observable Mitochondrial-Membrane-Potential was
linked to the sum of Mitochondrial-Membrane-Potential-new and
–old. A legend of all the names (e.g. species, parameters,
observables, etc.) used in the model is provided in Table S2 and
a complete list of model ODEs is provided in Table S3.
Parameter estimation and identifiability
The Matlab Toolbox PottersWheel 3.0.12 [61] and the
PottersWheel identifiability toolbox MOTA [62] were used for
estimating the kinetic rate constants in 7 rounds of parameter
estimation and identifiability (Table S4). All parameters were fitted
within the interval [1e206, 1e+04]. The kinetic rate constants
determining the activation/inactivation for IKK-b were assumed
a priori due to lack of clear experimental data. IKK-b is not an
essential component of this model as it only represents an
intermediate step between ROS and mTORC1, but we opted to
include it as we wanted to make an explicit connection between
oxidative stress-inflammation [59] and inflammatory-dependent
mTORC1 activation [63]. The remaining 39 parameters were
calibrated using the optimisation algorithm TrustRegion (MaxIter:
150; TolFun: 1e206; TolX: 1e206) and Matlab integration
algorithm ode15s (AbsTol: 1e206; RelTol: 1e204; MaxNum-
Steps: 1500). For each round, 40 independent sequences of 500 fits
each were performed and combined to generate a total of 20,000
fits, which were used for analysis. All the sequences were always
computed using the best current fit as the initial assignment and
randomising it with disturbance strength of 0.4. This strategy
allowed us to explore the parameter space extensively and
additionally, to limit the number of non-convergent solutions.
To calculate the sequences, a cluster of 6 GNU/Linux computers
with a total of 60 cores was employed using the open source job
scheduler Openlava (http://www.openlava.org/). As the standard
deviation of the experimental time points was often large, a 10%
error model of observation was adopted for the task of parameter
estimation. This improved the approximation of the model to the
data. For each round, nonlinear MOTA identifiability analysis was
used for identifying tuples of related parameters by selecting the
best 30% fits from the total 20,000 fits. A parameter was
considered non-identifiable when the correlation coefficient (CC)
and the coefficient of variance (CV) for the tuple of its related
parameters were higher than 25% and 0.9, respectively. The
MOTA identifiability matrices and the respective correlation plots,
as calculated for each round, are reported in Figure S4, S5, S6, S7,
S8, S9, S10, S11, S12, S13, S14, S15, S16, S17. To assess the
contribution to parameter estimation variability a principal
component analysis was performed at each round. Interestingly,
this analysis highlighted that at least half of the parameters
estimated at each round did not affect the model variance (Figure
S18).
Modelling tasks
Copasi 4.8.35 [64] was used for simulations with perturbation of
model species. Simulations were run for protein inhibition at 10
levels from 0% (control) to 90% for mTORC1 (simulating
Rapamycin treatment), Akt-mTORC1 (simulating Torin treat-
ment) and ROS. Simulations were run for protein over-activation
at 10 levels from 0% (control) to 150% for AMPK, FoxO3a and
Mitophagy. For the species in which the sum of the two internal
activation/inactivation states was constant (e.g. mTORC1, Akt-
mTORC1 and AMPK), the protein amount was simply perturbed
at the beginning of the simulation. For species whose level varies
over the time-course (e.g. ROS, FoxO3a and Mitophagy), their
protein amount was constantly modified using a dummy species
introduced for each of the above species. Hence, these dummy
species simulated either an activator or an inhibitor. The kinetic
rate for this external perturbation was fixed, but, the amount for
these dummy species was determined such that the average
activation level for the perturbed protein species over the time
course was 10% (if inhibited) or 250% (over-activation) with
respect to the average activation level for the corresponding
unperturbed protein species (Figure S19). Deterministic simula-
tions were performed in Copasi using the deterministic algorithm
LSODA, configured with the following parameters: duration, 21;
interval size, 0.02; intervals, 1050; integrate reduced model, 0;
relative tolerance, 161026; absolute tolerance, 1610212; maxi-
mum internal steps, 10,000. Stochastic simulations were per-
formed in Copasi using the Direct Method (Gillespie), configured
with the following parameters: duration, 21; interval size, 0.01;
intervals, 2100; maximum internal steps, 100,000; use random
seed, 0; random seed, 1. Model 2D sensitivity analysis for model
species was computed at days 1, 10 and 20 by perturbing the
kinetic rate constant values. Double perturbation data were
computed using Copasi and Matlab by inhibiting or over-
activating the two parameters from 0% to 90% (inhibition) or
0% to 150% (over-activation) by steps of 0.15% and 0.25%
respectively. Lyapunov exponents for the reduced system were
computed in Copasi using the Wolf Method, configured with the
following parameters: number of exponents, 19; start averaging
after t, 21; orthonormalisation interval, 0.0001; overall time, 50;
relative tolerance, 161026; absolute tolerance, 1610210; maxi-
mum internal steps, 10,000. The divergence was calculated as the
average over the trace of the Jacobian as implemented in Copasi.
Model structure was graphically represented using CellDesigner
[65,66] and exported to SBML [67] Level 2 Version 4 using
Potterswheel (Model S1).
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Statistics
The programming language R (http://cran.r-project.org/) was
used for computing time course mean and standard deviation of 5
independent in vitro time-course measurements. Mean and
standard deviation values were then used for calibrating the
model observables. The goodness-of-fit statistical measures x2 [61]
and AIC [68] were used to assess the quality of fit of the model at
each calibration round. All these measures were directly computed
using the PottersWheel toolbox. R was selected for the graphic
representation of the identifiability matrix computed with MOTA
and single perturbation plots. For establishing the model
parameterisation, in vitro experiments were performed with
between 3 and 5 independent replicates. Intervention experiments
were performed in triplicate, except for SA-b-gal staining, which
was performed in duplicate. For data that were not normally
distributed, group means were compared using a Mann–Whitney
rank sum test. Multiple comparisons were performed by ANOVA
followed by Dunn’s test for comparison of individual subgroups.
All analyses were performed in Sigmaplot or R unless stated
otherwise. Data were tested for normality using Shapiro-Wilk
normality test. Significance is denoted on all graphs with * p,
0.05.
Antibodies
The full list of antibodies with their respective catalogue
numbers and the dilutions used for the respective staining (western
or immunofluorescence) is provided in Table S5.
Cell culture
MRC-5 human embryonic lung fibroblasts (obtained from
ECACC) were grown in Dulbecco’s Modified Eagle’s Medium
plus 10% fetal calf serum (BioSera, Ringmer, UK), 2 mM L-
glutamine, 16 penicillin/streptomycin at ambient oxygen partial
pressure, 5% CO2, 37uC in a humidified incubator (Binder
Instruments). All experiments utilised cells which were growing in
the logarithmic part of their growth curves. For irradiation, cells
were plated to give approximately 80% confluency just prior to
irradiation. 20 Gy X-irradiation was given to the cells using an X-
rad225 irradiator (Precision x-ray Inc., N.Branford, CT USA) to
induce senescence. Post irradiation, cells were immediately
supplied with fresh medium, and then fed three times a week
over the timecourse (with or without drugs/DMSO each time). 0
day timepoints were unirradiated and harvested 2 hours after
treating with their respective drugs if necessary. Antioxidant
treatment was performed with the addition of 100 IU SOD and
100 IU catalase to the medium as described previously [12].
mTOR inhibition was performed using Torin 1 (Tocris Biosci-
ence, Bristol) at 10 nM. Bafilomycin A treatment was performed
for 1 hour at 400 nM.
Western analysis
26105 cells were plated in 60 mm petri dishes (Corning) 1 day
prior to irradiation. Medium was removed and cells were washed
once with PBS before harvesting by scraping directly in SDS
loading buffer, transferred to screw cap microcentrifuge tubes,
boiled for 5 minutes, then stored at 220uC until required.
Samples were run on 10% SDS-PAGE gels (Biorad) before
transferring to PVDF (Biorad). Membrane washes and antibody
dilutions were performed using Tris-buffered saline with 0.1% (v/
v) Tween20 (TBST). All primary antibody incubations were
performed in TBST with 5% BSA, overnight at 4uC before
washing, applying HRP-conjugated secondary antibody (NEB) for
1 h at room temperature and subsequently detecting HRP activity
using Supersignal West Pico substrate (ThermoScientific, Cram-
lington, UK) with a LAS4000 imager (Fujifilm, Japan).
Immunofluorescence
2.56104 cells were plated on 16 mm Ø glass coverslips (#1.5) in
12 well plates (Corning) 1 day prior to irradiation. Medium was
removed and wells were washed once with PBS before adding
250 ml of pre-warmed 4% paraformaldehyde (PFA) and incubat-
ing at 37uC for 2 minutes. PFA was removed and wells were
washed 3 times with PBS. Cells were stored in 2 ml of PBS at 4uC
until required. For immunostaining, TBS was used for all washes,
and antibody incubations were performed using TBS plus 0.3%
(v/v) Triton X-100. All primary antibody incubations were
performed overnight at 4uC, with secondary detection using
AlexaFluor conjugated antibodies (Life technologies, Paisley, UK)
for 1 h at room temperature. Coverslips were mounted using
Prolong Gold with DAPI (Life technologies). Imaging was
performed using a spinning disk confocal head (CSU-X1,
Yokogawa, Japan) mounted on an Axiovert 200M equipped with
a 636 NA1.4 objective driven by Axiovision software (v4.8.1,
Zeiss, Cambridge, UK). Each position was captured as a z stack
and deconvolved using Huygens (v4.2, SVI, Netherlands).
Fluorescent intensities and cH2A.X foci counts were calculated
using ImageJ (v1.45j, http://rsb.info.nih.gov/ij/). Number of
colocalised objects in LC3- COXIV stained cells were determined
using Huygens Colocalisation analyser.
Live cell microscopy
Mitochondrial mass and ym were determined by fluorescence
microscopy using TMRM and Mitotracker Green as described
previously (Passos et al., 2010), analysing at least 100 cells per
treatment and time point. For following mitochondrial dynamics,
cells were transduced with baculovirus encoding mitochondrially
targeted red fluorescent protein following the manufacturer’s
protocol (Invitrogen). Single cell images were captured using a
Zeiss CellObsever spinning disk confocal equipped with a heated,
humidified stage (95% air, 5% CO2) using a 1006 1.4NA
objective (Zeiss) as a z stack encompassing the entire cell every 20 s
for 30 minutes. Images were then deconvolved with Huygens and
objects identified using the same parameters between cells with
Huygens Object Analyzer. For each cell, an 18.2 mm2 area was
then cropped out and the total mitochondrial volume of the object
identified time series were manually analysed over time for
numbers of fusion and fission events per time point (every 20 s).
Huygens was used to determine the total mass at each time point
in the cropped regions. Total fusion and total fission events per
minute were then summed every minute over the time course. To
measure mitophagy, cells were transduced with baculovirus
encoding mitochondrially targeted red fluorescent protein and
lysosomally targeted green fluorescent protein following the
manufacturer’s protocol (Invitrogen). Images were acquired and
processed as described for LC3-COXIV stained cells.
Flow cytometry
Flow cytometric measurements of mitochondrial mass and
superoxide measurements (using mitotracker green and DHE
respectively) were performed as described previously (Passos et al.,
2007), analysing 30,000 cells per treatment and time point.
Supporting Information
Figure S1 Measures of mitophagy during stress induced
senescence. (A) Cells were fixed at the indicated timepoint with
or without 1 hour pre treatment with 400 nM Bafilomycin A, and
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then stained for LC3 and COX-IV. Number of co-localised
objects were determined as described in the Methods. Replica-
tively senescent MRC5 cells were included as a positive control. (B)
Live cell microscopy was performed using co-transduction of GFP
and RFP targeted lysosome and mitochdondrial baculovirus
constructs respectively at the timepoints shown. Bafilomycin A
treatment and analysis were performed as described for LC3-
COX-IV stained cells.
(TIF)
Figure S2 Mitochondrial mass data as determined by
flow cytometry. Cells loaded with Mitotracker Green were
analysed by flow cytometry at the time points indicated post 20 Gy
irradiation. Data represent the median fluorescence intensity from
30,000 cells per time point relative to the 0 day control.
(TIF)
Figure S3 Cell viability. Cell viability was determined from
trypsinised cells (plus spent medium) at the indicated time points
post 20 Gy irradiation by counting live/dead cells using trypan
blue and a haemocytometer. A minimum of 120 cells were
recorded per dish per time point, 3 dishes per time point. Data are
mean +/2 SD. No significant changes in viability were seen over
time.
(TIF)
Figure S4 MOTA identifiability matrix for round 1 of
parameter estimation. In this round the kinetic rate constants
k3, k4, k17, k18, k19, k20, and k37 were fixed since they were
identifiable using MOTA identifiability analysis. *: Correlation
Coefficient (CC).0.9 and Coefficient of Variation (CV).0.25; **:
Correlation Coefficient (CC).0.9, Coefficient of Variation (CV).
0.25 and number of tuples showing this correlation (#).1.
Format: ParameterCode ,CC CV # (‘‘Tuple of related
parameters’’)..
(TIF)
Figure S5 Correlation plots for round 1 of parameter
estimation, as detected by MOTA identifiability analy-
sis. Plots for the tuples of related parameters reported in the
MOTA identifiability matrix in Figure S4.
(TIF)
Figure S6 MOTA identifiability matrix for round 2 of
parameter estimation. In this round the kinetic rate constants
k1, k2, k15, k16, k21, k30, k35, and k36 were fixed since they were
identifiable using MOTA identifiability analysis.
(TIF)
Figure S7 Correlation plots for round 2 of parameter
estimation, as detected by MOTA identifiability analy-
sis. Plots for the tuples of related parameters reported in the
MOTA identifiability matrix in Figure S6.
(TIF)
Figure S8 MOTA identifiability matrix for round 3 of
parameter estimation. In this round the kinetic rate constants
k25, k26, and k32 were fixed since they were identifiable using
MOTA identifiability analysis. The parameters k8, k9, and k12
were locked as reported in Table S4. The parameters k8 and k9
were part of two couples of related parameters. The former k8
with k7, the latter k9 with k10. All these two couples only related
internally with themselves and therefore formed two locally
defined correlations. The parameter k12 only related with k11,
although k11 was not dependent on k12. Hence, this also formed a
locally defined correlation.
(TIF)
Figure S9 Correlation plots for round 3 of parameter
estimation, as detected by MOTA identifiability analy-
sis. Plots for the tuples of related parameters reported in the
MOTA identifiability matrix in Figure S8.
(TIF)
Figure S10 MOTA identifiability matrix for round 4 of
parameter estimation. In this round the kinetic rate constants
k7, k10, k11, k13, k14, and k33 were fixed since they were
identifiable using MOTA identifiability analysis.
(TIF)
Figure S11 Correlation plots for round 4 of parameter
estimation, as detected by MOTA identifiability analy-
sis. Plots for the tuples of related parameters reported in the
MOTA identifiability matrix in Figure S10.
(TIF)
Figure S12 MOTA identifiability matrix for round 5 of
parameter estimation. In this round the kinetic rate constants
k34, k38, k40, and k41 were fixed since they were identifiable
using MOTA identifiability analysis.
(TIF)
Figure S13 Correlation plots for round 5 of parameter
estimation, as detected by MOTA identifiability analy-
sis. Plots for the tuples of related parameters reported in the
MOTA identifiability matrix in Figure S12.
(TIF)
Figure S14 MOTA identifiability matrix for round 6 of
parameter estimation. In this round the kinetic rate constants
k22, k23, k24, and k39 were fixed since they were identifiable
using MOTA identifiability analysis.
(TIF)
Figure S15 Correlation plots for round 6 of parameter
estimation, as detected by MOTA identifiability analy-
sis. Plots for the tuples of related parameters reported in the
MOTA identifiability matrix in Figure S14.
(TIF)
Figure S16 MOTA identifiability matrix for round 7 of
parameter estimation. In this round the kinetic rate constants
k5, k6, k29, and k31 were fixed since they were identifiable using
MOTA identifiability analysis.
(TIF)
Figure S17 Correlation plots for round 7 of parameter
estimation, as detected by MOTA identifiability analy-
sis. Plots for the tuples of related parameters reported in the
MOTA identifiability matrix in Figure S16.
(TIF)
Figure S18 Principal component analysis for model at
each round of parameter estimation. To further investi-
gate the source of variability, principal component analysis
(PCA) of the model was computed at each round of parameter
estimation. Interestingly, this analysis indicated that only about
half of the estimated parameters did not significantly contribute
to the overall variance for each round. This suggested that a
group of parameters could have been potentially identified at
each round.
(TIF)
Figure S19 Simulated tools for model inhibition or over-
activation over time. (A) To inhibit ROS over time, a
simulated ROS inhibitor species was added to the model. This
new species reduced ROS levels and acted as an in vitro ROS
scavenger. The abundance for this species was estimated in order
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to achieve ROS inhibition to 10% (blue) as compared to the
control (white) throughout the time course. (B) In analogy, two
new species were created for over-activating mitophagy and
FoxO3a, respectively. The abundance for these two species were
estimated to achieve a mitophagy or FoxO3a over-activation of
150% (magenta) as compared to the corresponding control
(white) throughout the time course. Each boxplot represents the
median and two quartiles, whereas the bars indicate the
minimum and the maximum values, as estimated from day 1 to
day 21.
(TIF)
Figure S20 Inhibition of ROS and mTOR in vitro. Torin
and ROS inhibition efficacy. (A) Cells were irradiated with
20 Gy X irradiation and then treated with Torin1 or DMSO as
described in Methods. Lysates were probed with total mTORC1
and mTORC1-S2448 antibodies. Band intensities were quan-
tified relative to Tubulin loading control and plotted as mean
+/2 SD ratios of mTORC1-S2448 to total mTORC1 (3
repeats). (B) Cells were irradiated with 20 Gy X irradiation and
then treated with SOD and catalase as described in Methods.
Cells were stained with DHE to measure intracellular superox-
ide levels by flow cytometry. Time course data over 21 days are
plotted (n = 3).
(TIF)
Figure S21 Analysis of the two mitochondrial sub-
populations upon ROS-mTOR combined intervention.
The internal states for the new and old mitochondrial sub-
populations were also investigated upon combined ROS-
mTOR simulated intervention. Regarding the mitochondrial
membrane potential, the global effect of these interventions
mainly resulted from changes in the sub-population of new
mitochondria, which showed a strong synergistic response at
particular levels of mTOR- ROS inhibition. The effect upon
old mitochondrial øm was almost entirely dependent upon
mTOR inhibition, but still changed their potential by an
insignificant amount compared to the new mitochondrial
population. Concerning the mitochondrial mass, the perturba-
tion of combined ROS-mTOR acted predominantly on the
young population, although these changes were largely hidden
in the overall population (Figure 4A) due to the larger
proportion being comprised of the old population. The point
(0, 0) indicates the control (no inhibition).
(TIF)
Figure S22 Analysis of senescence-associated b-galacto-
sidase staining upon upon ROS-mTOR combined inter-
vention. (A) Cells were fixed at the indicated timepoints and
assayed for senescence–associated b-galactosidase followed by
counterstaining with nuclear fast red prior to imaging. An
average of ,300 cells were counted per coverslip, with any blue
cytoplasmic staining being considered positive. Data are n = 2 6
SD. Combined intervention produced significantly lower
positive cells at 3 and 6 days post irradiation relative to DMSO
control (P,0.05). (B) Example images of stained coverslips
showing the decreased intensity of staining observed in treated
cells.
(TIF)
Figure S23 Additional readouts upon AMPK, FoxO3a or
mitophagy simulated over-activation. The model predicted
a decrease in the DNA damage/oxidative stress response pathways
upon over-activation of AMPK, FoxO3a or mitophagy. AMPK
was predicted to achieve the strongest inhibition throughout the
time course as compared to FoxO3a or mitophagy. Interestingly,
an over-activation of FoxO3a was predicted to initially increase
and then reduce CDKN1A levels as compared to the control
(black line), suggesting differential regulation of cell cycle arrest
over time.
(TIF)
Figure S24 Model stochastic simulation showed in-
crease stochasticity over time. Model stochastic simula-
tions up to 20 days graphically showed increased stochasticity
for the oxidative stress/DNA damage signalling species.
Moderate increased variance was also detected for the species
Mitophagy and the species representing mitochondrial mass
and membrane potential. Number of stochastic runs: 500;
black line indicates the means, dark grey area indicates 95%
confidence interval of the mean and grey area indicates a
standard deviation. (A) Species associated to in vitro data
(observable variables). (B) Mitochondrial internal states (de-
rived variables).
(TIF)
File S1 File collecting all the supporting tables and
figures. All the supporting tables and figures with their
corresponding legends are combined into one document in this
file.
(PDF)
Model S1 SBML code for the model.
(XML)
Movie S1 Mitochondrial fusion and fission in young and
senescent fibroblasts over 30 minutes time courses.
(MP4)
Table S1 In vitro data set used for estimating the model
parameters. For each model observable, the mean and standard
deviation (reported as StdCol) of the quantified in vitro intensities
are reported. The table is formatted for Potterswheel v. 3.0.12.
(XLS)
Table S2 Legend of the model variables. This table defines
the unique codes for the model kinetic rate constants (Ki), species
(Xi), scaling factors (Si), observables (Yi) and constraints (CSi). The
values for the non-estimated parameters are also provided. The
lambda term in the block ‘Constraints’ defines the constraint
strength (higher values means harder constraints) as implemented
in PottersWheel.
(TIF)
Table S3 ODEs table of the model. The Ordinary
Differential Equations (ODEs) for the 23 species defining the
model.
(TIF)
Table S4 Table of the estimated parameters in the
model. Up to 7 rounds of alternated parameter estimation and
MOTA identifiability analysis were computed in order to
progressively determine all the kinetic rate constant parameters.
The internal round columns include the following labels: Assumed,
Fixed and Locked. A parameter was termed assumed when it was
assumed a priori, and therefore was not estimated. The only
assumed parameters were related to the IKK-b dynamics. A
parameter was termed fixed when it could be estimated and
identified based on MOTA analysis within a confidence of
variance lower than 25% or a correlation coefficient lower than
0.9. A parameter p was termed locked when it was fixed without
being completely identifiable according to MOTA analysis. This
was done only when 1) p belonged to a tuple of related parameters
and each parameter in this tuple only related to the same
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parameter tuple (e.g. case for k8, k9), or 2) the other parameters in
this tuple were not found to significantly relate with p, creating a
one-way correlation (e.g. case for k12, see Figure S8). Since these
correlations were local and completely confined to the tuple
parameters, they did not affect the other unrelated parameters.
The parameters in the tuple were only linearly affected. MOTA
correlation matrices and plots are provided in Figures S4, S5, S6,
S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, and computed
from the best 30% of 20,000 fits (see Materials and Methods for
more details). For each parameter, the final value, mean, standard
deviation and coefficient of variance are reported. Interestingly,
parameter estimation reported an extremely low value for the
parameter k5, suggesting a poor ATP production by dysfunctional
mitochondria. Among the three modalities of mTORC1 activa-
tion (amino acids only, amino acids + insulin, amino acids +
IKK-b; parameters k6, k7 and k29, respectively), it was detected
that mTORC1 activation was significantly stronger in the
presence of insulin. Finally, parameter estimation also suggested
that the increase in SA-b-gal (see k30, k31) was largely dependent
on ROS rather than mitophagy.
(TIF)
Table S5 List of antibodies. The antibodies used in this study
are shown, with their respective catalogue numbers and the
dilutions used for the respective staining (western or immunoflu-
orescence).
(TIF)
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